A phase II cluster study of single agent AUY922, BYL719, INC280, LDK378, and MEK162 in Chinese patients with advanced non-small cell lung cancer (NSCLC).
Qing Zhou
No relevant relationships to disclose
Xu-Chao Zhang
No relevant relationships to disclose
Bin Peng
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Xiaolu Yu
No relevant relationships to disclose
Mikhail Akimov
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Barbara Lynn Weber
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Yi-Long Wu
Honoraria - AstraZeneca; Lilly; Roche